Vascular complications are the rarest but most serious risk category in filler treatment. They range from harmless bruising to genuine arterial events requiring medical emergency competence. This article situates what can happen — factually, without symptom triage and with a clear instruction to contact the practice in any doubt.
Note: probability vs. consequence
A systematic review by Beleznay et al. (2019) in the Aesthetic Surgery Journal describes filler-related vascular complications — the most severe courses are rare, but their consequences are potentially serious, including vision loss with centrally placed injections [1]. Low probability, high consequence — from this asymmetry follows: preparation and rapid response are central.
Treated medically, in a practice with documented emergency concept, hyaluronidase availability, and anatomical experience, the risk is minimised — but not eliminated. More in our article on provider red flags.
What vascular complications are
Harmless variant: bruising
Puncturing a small vessel produces bruising. Statistically common, clinically unimportant, resolves over 7–14 days. Not an emergency. A serious practice describes it as an expected phenomenon before treatment.
Venous congestion
When filler material compresses venous outflow, congestion symptoms can occur: bluish-livid discolouration, swelling, dull pressure. Often reversible, but requires prompt medical assessment.
Arterial complication
The most serious form: filler material enters an artery and causes ischaemia — oxygen deprivation in the supplied tissue. Possible consequences: skin discolouration, skin lesions, in central regions also ocular complications. A review by Sito et al. (2019) describes the clinical picture and time-critical therapy [2].
Therapeutic time window: hours, not days. Hyaluronidase availability and medical experience are the decisive factors. More in our article on hyaluronidase emergency use.
When the practice must be contacted immediately
This section names observations that warrant an immediate call to the treating practice. No self-diagnosis — orientation for contact:
Strongly unusual, intense pain — particularly pain clearly beyond what was felt during the procedure.
Skin discolouration spreading away from the treatment site, showing a streaky, mottled, or bluish pattern, or appearing whitish.
Visual disturbances of any kind after a facial injection. Even unspecific changes in eye perception are a compelling reason for immediate contact — seconds count.
Sudden, marked swelling with pressure pain that increases within a few hours.
Skin blisters, ulcers, or dark discolouration in or near the treatment area.
Acute numbness in an untreated area.
With any of these observations: do not wait, do not research, do not hope. Call the practice. If unreachable: nearest emergency department, noting the recent filler treatment.
What makes anatomy difficult
Certain facial regions have anatomical structures carrying higher risk for arterial complications — the glabella (frown line), nose, nasolabial folds, peri-orbital frame. Here arteries run partly close to the surface and connect to central supply lines. A study by Tansatit et al. (2017) describes the microanatomical complexity of these areas [3].
Translation: medical experience treating these regions is not optional but central. A practice treating these areas without documented anatomical training takes systemic risks.
What a practice does to minimise risk
Anatomical knowledge and experience — beyond textbooks, hands-on practice in the relevant region.
Aspiration test before each injection in high-risk areas — not full protection, but additional safety layer.
Slow injection at low pressure — reduces risk of intravascular material distribution.
Microcannulas instead of needles in suitable areas — smaller injury risk, but not applicable everywhere.
Hyaluronidase in the treatment room — the only time-critical emergency substance for HA complications.
Documented and rehearsed emergency algorithm.
FAQ
How frequent are serious vascular complications?
Very rare, in the per-mille range or below with medical use. They occur not reproducibly but regularly enough to justify continuous preparation by every treating practice.
Which areas carry the highest risk?
Glabella, nose, nasolabial folds, and peri-orbital region. Areas with surface-near arteries and anatomical connections to central supply lines.
Do microcannulas fully protect against vascular complications?
No. They reduce injury risk but do not eliminate it. Anatomical knowledge and care remain central.
How quickly must I act on suspicion?
Immediately. With suspected arterial complication, hours count for hyaluronidase therapy effectiveness. Delay can render the course irreversible.
Can I recognise vascular complications?
Observe, yes. Diagnose, no — that is medical work. What you can observe is described in the section above. With any of these observations: contact the practice.
Which practice should I choose to minimise risk?
A medical practice with documented filler experience, anatomical training, emergency equipment including hyaluronidase, clearly documented emergency algorithm, and reachability after treatment. More in our article on provider red flags.
What if the practice deflects?
With acute symptoms not taken seriously: contact a second practice or go to an emergency department. Assessment must be medical and prompt, not telephonic reassurance.
Acute? Contact the treating practice immediately — no self-diagnosis. § 9 HWG (German Medicines Advertising Act) prohibits remote diagnosis. This article does not replace medical judgement.
References
- [1] Beleznay K, Carruthers JDA, Humphrey S, et al. Update on Avoiding and Treating Blindness From Fillers: A Recent Review of the World Literature. Aesthetic Surgery Journal. 2019;39(6):662-674. PubMed: 30649151
- [2] Sito G, Manzoni V, Sommariva R. Vascular Complications after Facial Filler Injection. Journal of Clinical and Aesthetic Dermatology. 2019;12(6):E65-E72. PubMed: 31360298
- [3] Tansatit T, Apinuntrum P, Phetudom T. Facing the Worst Risk: Confronting the Dorsal Nasal Artery. Aesthetic Plastic Surgery. 2017;41(1):191-198. PubMed: 27896394
Last reviewed: May 2026. This article does not replace medical advice. Individual results may vary.
